APLS — APELLIS PHARMACEUTICALS INC

Ownership history in Scientech Research LLC  ·  3 quarters on record

This page tracks every 13F SEC filing in which Scientech Research LLC reported a position in APELLIS PHARMACEUTICALS INC (APLS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.27% (2025 Q3)
Avg. % of fund
0.18%
First filed
2024 Q4
Last filed
2025 Q3
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 34,182 +10,787 +46.1% 0.27% $774K $22.63
2025 Q1 ADDED 23,395 +9,062 +63.2% 0.14% $512K $21.87
2024 Q4 INITIATED 14,333 — — 0.13% $457K $31.91
% of Fund (quarterly)    APLS price (monthly, adj. close)

Other funds also holding APLS

As of 2025 Q4 — sorted by position size

Deep Track Capital, LP 3Y 3.47% Avoro Capital Advisors LLC 3Y 7Y 3.02% SUVRETTA CAPITAL MANAGEMENT, LLC 3Y 7Y 2.13% Siren, L.L.C. 1.93% RTW INVESTMENTS, LP 3Y 7Y 1.93% Exome Asset Management LLC 1.63% Logos Global Management LP 3Y 1.52% Kynam Capital Management, LP 3Y 1.46% ORBIMED ADVISORS LLC 3Y 7Y 1.25% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 1.22%
← Back to Scientech Research LLC Holdings